Literature DB >> 21779006

Leukaemia and lymphoma: The expansive reach of TET2.

Gemma K Alderton.   

Abstract

Entities:  

Year:  2011        PMID： 21779006     DOI： 10.1038/nrc3115

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  3 in total

1.  TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis.

Authors:  Cyril Quivoron; Lucile Couronné; Véronique Della Valle; Cécile K Lopez; Isabelle Plo; Orianne Wagner-Ballon; Marcio Do Cruzeiro; Francois Delhommeau; Bertrand Arnulf; Marc-Henri Stern; Lucy Godley; Paule Opolon; Hervé Tilly; Eric Solary; Yannis Duffourd; Philippe Dessen; Hélène Merle-Beral; Florence Nguyen-Khac; Michaëla Fontenay; William Vainchenker; Christian Bastard; Thomas Mercher; Olivier A Bernard
Journal:  Cancer Cell       Date:  2011-06-30       Impact factor: 31.743

2.  Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation.

Authors:  Kelly Moran-Crusio; Linsey Reavie; Alan Shih; Omar Abdel-Wahab; Delphine Ndiaye-Lobry; Camille Lobry; Maria E Figueroa; Aparna Vasanthakumar; Jay Patel; Xinyang Zhao; Fabiana Perna; Suveg Pandey; Jozef Madzo; Chunxiao Song; Qing Dai; Chuan He; Sherif Ibrahim; Miloslav Beran; Jiri Zavadil; Stephen D Nimer; Ari Melnick; Lucy A Godley; Iannis Aifantis; Ross L Levine
Journal:  Cancer Cell       Date:  2011-06-30       Impact factor: 31.743

3.  Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors.

Authors:  Elodie Pronier; Carole Almire; Hayat Mokrani; Aparna Vasanthakumar; Audrey Simon; Barbara da Costa Reis Monte Mor; Aline Massé; Jean-Pierre Le Couédic; Frédéric Pendino; Bruno Carbonne; Jérôme Larghero; Jean-Luc Ravanat; Nicole Casadevall; Olivier A Bernard; Nathalie Droin; Eric Solary; Lucy A Godley; William Vainchenker; Isabelle Plo; François Delhommeau
Journal:  Blood       Date:  2011-07-06       Impact factor: 22.113
  3 in total
  3 in total

1.  PML Recruits TET2 to Regulate DNA Modification and Cell Proliferation in Response to Chemotherapeutic Agent.

Authors:  Chengli Song; Lina Wang; Xiaoyan Wu; Kai Wang; Dan Xie; Qi Xiao; Songyu Li; Kui Jiang; Lujian Liao; John R Yates; Jiing-Dwan Lee; Qingkai Yang
Journal:  Cancer Res       Date:  2018-05-07       Impact factor: 12.701

2.  DMSO is a strong inducer of DNA hydroxymethylation in pre-osteoblastic MC3T3-E1 cells.

Authors:  Roman Thaler; Silvia Spitzer; Heidrun Karlic; Klaus Klaushofer; Franz Varga
Journal:  Epigenetics       Date:  2012-06-01       Impact factor: 4.528

3.  IDH1/2 Mutants Inhibit TET-Promoted Oxidation of RNA 5mC to 5hmC.

Authors:  Qiang Xu; Kai Wang; Lina Wang; Yuting Zhu; Guangyu Zhou; Dan Xie; Qingkai Yang
Journal:  PLoS One       Date:  2016-08-22       Impact factor: 3.752
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.